Company intelligence / Profile preview

Marble Therapeutics

Unknown, Unknown, Unknownkeionline.org ↗

Ownership: Private
Development stage: Other

Overview

Marble Therapeutics is a preclinical-stage biotech startup developing adeno-associated virus-based gene therapies for genetic skin diseases and age-related skin rejuvenation. There are no reported clinical results as of early 2024.

Therapeutic areas: Dermatology
Modalities: Gene therapyAdeno-associated virus-based therapy
Industry: Biotech

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of February 2024. The company has sought an exclusive patent license from NIH for vaccine augmented adoptive cell therapy in cancer but this does not appear to be its primary area.

Beyond the preview

Go deeper on Marble Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marble Therapeutics.

Explore the full profile